Impact of COVID-19 on risks and deaths of non-communicable diseases in the Western Pacific region.

COVID-19 Mortality NCDs Western Pacific region

Journal

The Lancet regional health. Western Pacific
ISSN: 2666-6065
Titre abrégé: Lancet Reg Health West Pac
Pays: England
ID NLM: 101774968

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 09 03 2023
revised: 08 04 2023
accepted: 04 05 2023
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: epublish

Résumé

Countries and areas in the Western Pacific region (WPR) experienced the COVID-19 pandemic and took various preventive measures, which affected non-communicable diseases (NCDs) risks and mortality. Due to differences in COVID-19 prevention measures and other characteristics such as culture, religions, political systems, socioeconomic development, lifestyles, and health care systems, the effects of COVID-19 on NCDs varied greatly among WPR countries. Most countries had an increased all-cause and NCDs mortality during the pandemic, but some developed countries, including New Zealand, Singapore and Australia reported decreased mortality. The pandemic and the preventive measures increased NCD risk factors including unhealthy diet, lack of physical activity and sleep disorders. The effects varied by socioeconomic status and health conditions. COVID-19 related stress, food shortages, and confined lifestyle had immediate detrimental effects on NCDs, and also affected pregnancy outcomes with long-term effects on NCDs risks in coming years.

Identifiants

DOI: 10.1016/j.lanwpc.2023.100795 PMID: 38456087 PMC: PMC10920048
pubmed: 38456087
doi: 10.1016/j.lanwpc.2023.100795
pii: S2666-6065(23)00113-X
pmc: PMC10920048
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100795

Informations de copyright

© 2023 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declared no conflict of interest.

Auteurs

Xiaoyue Xu (X)

School of Population Heath, University of New South Wales, Australia.

Zumin Shi (Z)

Human Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha, 2713, Qatar.

Lihui Zhou (L)

School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.

Jing Lin (J)

School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.

Evan Atlantis (E)

School of Health Sciences, Western Sydney University, Penrith, New South Wales, Australia.
Discipline of Medicine, Nepean Clinical School, Faculty of Medicine and Health, The University of Sydney, Nepean, New South Wales, Australia.

Xinguang Chen (X)

The First Affiliated Hospital of Xi'an Jiaotong University Public Health Institute, Global Health Institute, School of Public Health, International Obesity and Metabolic Disease Research Center, Xi'an Jiaotong University, Xi'an 710061, People's Republic of China.

Akhtar Hussain (A)

Faculty of Health Sciences, Nord University, Bodø, 8049, Norway.
International Diabetes Federation, 166 Chaussee de La Hulpe, B-1170, Brussels, Belgium.

Youfa Wang (Y)

The First Affiliated Hospital of Xi'an Jiaotong University Public Health Institute, Global Health Institute, School of Public Health, International Obesity and Metabolic Disease Research Center, Xi'an Jiaotong University, Xi'an 710061, People's Republic of China.

Yaogang Wang (Y)

School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China.
National Institute of Health Data Science at Peking University, Peking University, Beijing, People's Republic of China.

Classifications MeSH